Results 131 to 140 of about 136,452 (263)

Effectiveness of intermittent hypoxia on muscle recovery in rats: A systematic review

Animal Models and Experimental Medicine, EarlyView.
This systematic review of animal studies evaluated intermittent hypobaric hypoxia (IHH), cold exposure, and their combinations, with or without exercise, on skeletal muscle recovery. IHH enhanced muscle regeneration, reduced fibrosis, improved contractile force, and maintained oxidative capacity, while cold exposure increased mitochondrial activity but
Sebastian Philippe Hansen Quiblier, María García‐Arrabé, Diego Domínguez‐Balmaseda, Guillermo García‐Pérez‐de‐Sevilla   +3 more
wiley   +1 more source

Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19. [PDF]

Pulm Ther
Merlo CA, Romdhani H, DerSarkissian M, Muthukumar A, McGarry LJ, Lou Y, Van Brunt K.   +6 more
europepmc   +1 more source

Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study

Annals of Neurology, EarlyView.
In multiple sclerosis (MS), anti‐CD20 therapies have been associated with increased infection risk, but whether this risk differs between rituximab and ocrelizumab is not known. Using a nationwide cohort, we studied infection risk and relapse outcomes among 16,872 treatment episodes with rituximab, ocrelizumab, or other disease‐modifying therapies ...
Thomas Frisell, Sebastian Hedberg, Fredrik Piehl   +2 more
wiley   +1 more source

Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single‐Arm Clinical Trial

Annals of Neurology, EarlyView.
Objective To evaluate the effectiveness and safety of ocrelizumab in self‐identified black and Hispanic people with relapsing multiple sclerosis. Methods The Characterization of Ocrelizumab in Minorities with Multiple Sclerosis (CHIMES) trial, a prospective, open‐label, single‐arm, phase 4 study, intentionally recruited underrepresented populations in ...
Lilyana Amezcua, Anthony T. Reder, Evanthia Bernitsas, Nancy L. Monson, Timothy Vartanian, Gregory F. Wu, Mansoor Saleh, Annette Okai, Ahmed Z. Obeidat, Dilraj Sokhi, Rikisha Parekh, Jinglan Pei, Christopher Harp, David Clayton, Ibraheem Abioye, Mitzi J. Williams, for the CHIMES Study Group   +16 more
wiley   +1 more source

Association Between SGLT2 Inhibitor Use and Hepatocellular Carcinoma Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]

Biomedicines
Hu JH, Chang ML, Huang TJ, Liu NJ, Tang JH.   +4 more
europepmc   +1 more source

Public health interventions to improve the mental health and mental health literacy of young people in resource-limited settings: a systematic review. [PDF]

Front Public Health
Regeru RN, Massey K, Wee YR, Evans JS, Sylvester S.   +4 more
europepmc   +1 more source

Emerging robotic platforms in gynecologic surgery: a systematic review. [PDF]

J Robot Surg
Bruno M, Arrigo D, D'Indinosante M, Perrone E, Bizzarri N, Panico G, Macellari N, Figà M, Giménez M, Forgione A, Marescaux J, Fagotti A, Fanfani F.   +12 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and advanced liver outcomes in type 2 diabetes: a systematic review and exploratory meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Hu JH, Chang ML, Huang TJ, Liu NJ, Hsieh YY.   +4 more
europepmc   +1 more source

Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus. [PDF]

Metabol Open
Sharma PK, Viswaprasad V, Choudhary A, Nurulhasan AR, Redkar SV, Bharatkumar PM, Patil VS, Anand S, Barge V, Shah SJ, Patel CB, Sudheer K, Somani S, Rambabu K, Adhikarla SVK, Swapna M, Ankathi SK, Singh VB, Sarkar G, Gautam SK, Das KK, Tripathi KN, Bhattacharya R, Sudarsi B, Parmar D, Kansagra K, Pathak H.   +26 more
europepmc   +1 more source

Bayesian adaptive cluster-randomized designs with long primary endpoints for pragmatic weight loss studies implemented in rural communities. [PDF]

Contemp Clin Trials
Bernal J, Wick J, Befort C, Gajewski B.
europepmc   +1 more source